Baicalein and baicalin as Zika virus inhibitors

Oo, Adrian and Teoh, Boon Teong and Sam, Sing Sin and AbuBakar, Sazaly and Zandi, Keivan (2019) Baicalein and baicalin as Zika virus inhibitors. Archives of Virology, 164 (2). pp. 585-593. ISSN 0304-8608, DOI

Full text not available from this repository.
Official URL:


At present, there is no effective antiviral agent for Zika virus (ZIKV), an arbovirus that is known for its teratogenic effects on newborns. Baicalein and baicalin were found to be capable of downregulating ZIKV replication up to 10 hours postinfection, while prophylactic effects were evident in pre-treated cells. Baicalein exhibited its highest potency during intracellular ZIKV replication, whereas baicalin was most effective against virus entry. Our in silico interaction assays predicted that both compounds exhibited the strongest binding affinities towards ZIKV NS5, while the virus envelope glycoprotein was the least likely target protein. These findings serve as a crucial platform for further in-depth studies to decipher the underlying anti-ZIKV mechanism(s) of each compound. © 2018, Springer-Verlag GmbH Austria, part of Springer Nature.

Item Type: Article
Funders: University of Malaya via a Postgraduate Research Grant (PPP) (PG151-2016A)
Uncontrolled Keywords: Antiviral Agents; Flavanones; Flavonoids; Humans; Viral Envelope Proteins; Virus Internalization; Virus Replication; Zika Virus; Zika Virus Infection
Subjects: R Medicine
Divisions: Deputy Vice Chancellor (Research & Innovation) Office > Tropical Infectious Diseases Research and Education Centre
Depositing User: Ms. Juhaida Abd Rahim
Date Deposited: 14 Feb 2020 02:51
Last Modified: 14 Feb 2020 02:51

Actions (login required)

View Item View Item